Mingowood Pharmacal

Mingowood PharmacalMingowood PharmacalMingowood Pharmacal
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

  • Home
  • Technology
    • Our Science
    • Demonstration
    • Stability Studies
    • ATR-FTIR
    • Patents
    • FAQ
  • Solutions
    • For Pharma & Biotech
    • For Manufacturers
    • For Investors
  • Pipeline
  • About
    • Mission
    • The Problem We Solve
    • Licensing Model
    • Leadership
  • News
  • Contact
  • More
    • Home
    • Technology
      • Our Science
      • Demonstration
      • Stability Studies
      • ATR-FTIR
      • Patents
      • FAQ
    • Solutions
      • For Pharma & Biotech
      • For Manufacturers
      • For Investors
    • Pipeline
    • About
      • Mission
      • The Problem We Solve
      • Licensing Model
      • Leadership
    • News
    • Contact

Mingowood Pharmacal

Mingowood PharmacalMingowood PharmacalMingowood Pharmacal

Signed in as:

filler@godaddy.com

  • Home
  • Technology
    • Our Science
    • Demonstration
    • Stability Studies
    • ATR-FTIR
    • Patents
    • FAQ
  • Solutions
    • For Pharma & Biotech
    • For Manufacturers
    • For Investors
  • Pipeline
  • About
    • Mission
    • The Problem We Solve
    • Licensing Model
    • Leadership
  • News
  • Contact

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

ATR-FTIR Analysis - CBDA Formulation Stability

Additional Information

Reproduced Results

There was very little change over the entire spectrum for the three conditions analyzed: the initial control (blue), 48 hrs. at 60ᴼC (red), and 100 hrs. at 60ᴼC (gray) with samples 4,5 and 6.


Exceeded CBDA Half-life

The half-life of CBDA at 60° C is reported to be between 30 and 60 hours. 

Mingowood Pharmacal

Copyright © 2024 Mingowood Pharmacal - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept